Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 122531-09-3 | MDL No. : | MFCD11848566 |
Formula : | C8H5BrClN | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SMZUROGBNBCCPT-UHFFFAOYSA-N |
M.W : | 230.49 | Pubchem ID : | 14419619 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 51.01 |
TPSA : | 15.79 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.31 cm/s |
Log Po/w (iLOGP) : | 2.03 |
Log Po/w (XLOGP3) : | 3.37 |
Log Po/w (WLOGP) : | 3.58 |
Log Po/w (MLOGP) : | 2.87 |
Log Po/w (SILICOS-IT) : | 3.84 |
Consensus Log Po/w : | 3.14 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -4.0 |
Solubility : | 0.0232 mg/ml ; 0.000101 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.38 |
Solubility : | 0.0961 mg/ml ; 0.000417 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.76 |
Solubility : | 0.00401 mg/ml ; 0.0000174 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.5 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
15% | at -40℃; for 1 h; Inert atmosphere | under nitrogen gas, 1-bromo-2-chloro-4-nitrobenzene (57.4g, 0.243mol) dissolved in THF (500mL) and then , vinylmagnesium bromide (1M in THF, 728mL, 0.728mol) was slowly added dropwise in - 40 degree celcius followed by stirred at -40 degree celcius for 1 hour. Since, NH4After completion of the reaction with Cl aqueous solution was raised to room temperature.Then, the ethyl acetate was extracted into the organic layer, MgSO4to remove moisture in the organic layer, filtered and concentrated and purified by column chromatography using 5-bromo-6-chloro- 1H-indole (8.40g,Yield: 15percent) It was obtained. |
[ 30273-47-3 ]
4-Bromo-5-chloro-2-methylaniline
Similarity: 0.87
[ 30273-47-3 ]
4-Bromo-5-chloro-2-methylaniline
Similarity: 0.87